摘要
目的探讨Autar量表在肺癌患者经外周静脉置入中心静脉导管（PICC）相关性血栓风险评估的应用效果。方法将2008年1月至2012年12月在上海交通大学附属胸科医院进行PICC置管的1252例肺癌患者作为对照组，进行PICC常规置管及维护；将2013年1月至2016年5月在上海交通大学附属胸科医院进行PICC置管的1322例肺癌患者作为观察组，使用Autar量表进行评分，根据分值将患者分为低风险组、中风险组和高风险组，3组患者给予分级护理干预。结果对照组1252例置管患者38例发生PICC导管相关性血栓，血栓发生率为3．04％。观察组1322例患者发生PICC相关血栓12例，发生率为0．91％，其中低风险组、中风险组和高风险组患者血栓发生率分别为1．25％（5例）、1．04％（5例）和0．45％（2例）；观察组血栓发生率低于对照组（P〈0．05）。结论应用Autar量表能预警PICC的肺癌患者发生PICC相关性上肢静脉血栓发生风险，对高风险的肺癌患者采取预见性护理和治疗措施，有效控制患者PICC导管相关性血栓发生率。
Objective To evaluate the application of Autar scale in the assessment of the risk of thrombosis related to peripherally inserted central catheter （PICC） in patients with lung cancer. Methods 1 252 cases of lung cancer with PICC between January 2008 and December 2012 in Shanghai Chest Hospital were enrolled as the control group, who received routine PICC insertion and maintenance. 1 322 cases of lung cancer patients with PICC catheterization between January 2013 to May 2016 in the same hospital were recruited as the observation group, who were divided into low-risk, middle-risk and high-risk groups based on the scores of Autar scale, and given grading nursing intervention accordingly. Results In the control group, PICC-related thrombosis occurred in 38 cases （3.04%）. In the observation group, PICC-related thrombosis occurred in 12 cases （0.91%）, the incidence in the low-risk, middle-risk, and high-risk groups was 1.25% （5 cases）, 1.04% （5 cases） , and 0. 45% （2 cases） , respectively. The incidence of thrombosis is lower in the observation group than in the control group （ P 〈 0. 05 ）. Conclusions Autar scale may help anticipate the risk of PICC-related upper extremity venous thrombosis in patients with lung cancer. Preventive nursing and treatment measures in lung cancer patients at high risk may effectively reduce the incidence of PICC catheter-related thrombosis.
出处
《中华临床营养杂志》
CAS
CSCD
2016年第6期376-379,共4页
Chinese Journal of Clinical Nutrition
